1. Home
  2. IQV vs ROK Comparison

IQV vs ROK Comparison

Compare IQV & ROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • ROK
  • Stock Information
  • Founded
  • IQV 1982
  • ROK 1903
  • Country
  • IQV United States
  • ROK United States
  • Employees
  • IQV N/A
  • ROK N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • ROK Industrial Machinery/Components
  • Sector
  • IQV Health Care
  • ROK Industrials
  • Exchange
  • IQV Nasdaq
  • ROK Nasdaq
  • Market Cap
  • IQV 35.7B
  • ROK 32.8B
  • IPO Year
  • IQV 2013
  • ROK 1987
  • Fundamental
  • Price
  • IQV $200.02
  • ROK $271.30
  • Analyst Decision
  • IQV Strong Buy
  • ROK Buy
  • Analyst Count
  • IQV 17
  • ROK 19
  • Target Price
  • IQV $254.50
  • ROK $300.47
  • AVG Volume (30 Days)
  • IQV 1.4M
  • ROK 686.4K
  • Earning Date
  • IQV 02-06-2025
  • ROK 02-10-2025
  • Dividend Yield
  • IQV N/A
  • ROK 1.93%
  • EPS Growth
  • IQV 27.98
  • ROK N/A
  • EPS
  • IQV 7.62
  • ROK 8.28
  • Revenue
  • IQV $15,315,000,000.00
  • ROK $8,264,200,000.00
  • Revenue This Year
  • IQV $3.67
  • ROK N/A
  • Revenue Next Year
  • IQV $4.40
  • ROK $6.47
  • P/E Ratio
  • IQV $26.13
  • ROK $32.65
  • Revenue Growth
  • IQV 3.10
  • ROK N/A
  • 52 Week Low
  • IQV $187.62
  • ROK $242.81
  • 52 Week High
  • IQV $261.73
  • ROK $304.29
  • Technical
  • Relative Strength Index (RSI)
  • IQV 47.86
  • ROK 34.30
  • Support Level
  • IQV $195.99
  • ROK $274.45
  • Resistance Level
  • IQV $204.10
  • ROK $291.76
  • Average True Range (ATR)
  • IQV 4.78
  • ROK 5.53
  • MACD
  • IQV -0.26
  • ROK -0.95
  • Stochastic Oscillator
  • IQV 40.84
  • ROK 17.68

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About ROK Rockwell Automation Inc.

With roots tracing back to the early 1900s, Rockwell Automation is the successor to Rockwell International, which spun off its avionics segment in 2001. It is a pure-play industrial automation company that operates through three segments. Its largest segment by revenue, intelligent devices, sells factory floor-level devices such as motors, drives, sensors, relays, and actuators. Its software & control segment sells visualization, simulation, and human-machine interface software and control products such as programmable controllers, computers, and operator terminals. Its smallest segment, lifecycle services, offers digital consulting, engineered-to-order services, and other outsourced services such as remote monitoring, cybersecurity, and asset and plant maintenance and optimization.

Share on Social Networks: